Tallinn, Estonia

Ants Maasalu

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Tallin, EE (2018)
  • Tallinn, EE (2017 - 2021)

Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ants Maasalu

Introduction

Ants Maasalu, an esteemed inventor based in Tallinn, Estonia, has contributed significantly to the field of pharmaceuticals with his remarkable inventions. Holding a total of five patents, Maasalu's innovations particularly focus on the analogs of pridopidine, which serve as potential advancements in the treatment of neurological conditions.

Latest Patents

Maasalu's latest patents include groundbreaking methods for isolating compounds that have shown promise in medical applications. One notable invention outlines a process for preparing various analogs of pridopidine, specifically detailing compounds such as 4-(3-(methylsulfonyl)phenyl)-1-propylpiperidin-4-ol and 1-(3,3-bis(3-(methylsulfonyl)phenyl)propyl)-4-(3-(methylsulfonyl)phenyl)piperidone. These patents describe methods for both producing these compounds and utilizing them as reference standards to detect impurities in pharmaceutical formulations. The intricacies of his inventions not only enhance the preparation of pridopidine drug products but also streamline their distribution, showcasing the innovative spirit of Ants Maasalu.

Career Highlights

Throughout his career, Maasalu has made significant strides while working with prominent companies in the pharmaceutical industry. He has been part of Prilenia Neurotherapeutics Ltd., where his research and development efforts have been directed towards novel therapeutic solutions. Additionally, his experience at Cambrex Karlskoga AB has further solidified his expertise in the preparation and processing of pharmaceutical compounds.

Collaborations

Ants Maasalu has collaborated with esteemed colleagues in his field, including Malle Schmidt and Marit Laos. These partnerships have significantly contributed to his research endeavors and patent development, fostering a collaborative environment for innovation and discovery in pharmaceuticals.

Conclusion

Ants Maasalu’s contributions to pharmaceutical innovations, particularly in the realm of pridopidine analogs, are commendable. Through his extensive patent portfolio and collaborative efforts, he continues to pave the way for advancements in medical science, making a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…